Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.10, 2003-10, pp. : 1545-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity

By Supuran Claudiu T Fiore Anna Di Simone Giuseppina De

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 383-392

Informa Healthcare

Access to resources Recommend Favorite

Carbonic anhydrase inhibitors: an editorial

By Supuran Claudiu T

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 677-679

Informa Healthcare

Access to resources Recommend Favorite

Safety of carbonic anhydrase inhibitors

By Swenson Erik R

Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. : 459-472

Informa Healthcare

Access to resources Recommend Favorite

Antiobesity Carbonic Anhydrase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 879-884

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase/COX-2 inhibitors in the treatment of various diseases

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1803-1806

Informa Healthcare

Access to resources Recommend Favorite